USD 0.08
(-23.18%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 31.06 Million USD | -1.18% |
2022 | 27.23 Million USD | -1.61% |
2021 | 27.68 Million USD | 29.29% |
2020 | 21.41 Million USD | 40.58% |
2019 | 15.23 Million USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 6.01 Million USD | -23.95% |
2024 Q2 | 10.97 Million USD | 99.23% |
2023 Q1 | 6.99 Million USD | -5.6% |
2023 Q3 | 6.72 Million USD | -19.99% |
2023 Q2 | 8.4 Million USD | 20.23% |
2023 FY | 26.91 Million USD | -1.18% |
2023 Q4 | 7.9 Million USD | 17.58% |
2022 Q2 | 6.39 Million USD | 12.86% |
2022 Q1 | 5.66 Million USD | -21.04% |
2022 FY | 27.23 Million USD | -1.61% |
2022 Q4 | 7.4 Million USD | -4.64% |
2022 Q3 | 7.76 Million USD | 21.4% |
2021 FY | 27.68 Million USD | 29.29% |
2021 Q1 | 6.92 Million USD | 29.29% |
2021 Q4 | 7.17 Million USD | 0.39% |
2021 Q3 | 7.14 Million USD | 3.31% |
2021 Q2 | 6.92 Million USD | 0.0% |
2020 Q3 | 5.35 Million USD | 0.0% |
2020 Q1 | 5.35 Million USD | 40.58% |
2020 FY | 21.41 Million USD | 40.58% |
2020 Q4 | 5.35 Million USD | 0.0% |
2020 Q2 | 5.35 Million USD | 0.0% |
2019 Q2 | 3.8 Million USD | 0.0% |
2019 Q3 | 3.8 Million USD | 0.0% |
2019 FY | 15.23 Million USD | 0.0% |
2019 Q1 | 3.8 Million USD | 0.0% |
2019 Q4 | 3.8 Million USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Amgen Inc. | 19.73 Billion USD | 99.843% |
AstraZeneca PLC | 37.54 Billion USD | 99.917% |
Biogen Inc. | 7.3 Billion USD | 99.575% |
Gilead Sciences, Inc. | 21.14 Billion USD | 99.853% |
MIRA Pharmaceuticals, Inc. | -8.52 Million USD | 464.319% |
Scilex Holding Company | 31.06 Million USD | 0.0% |